Exagen_Full_RGB_Yahoo_600x216.png
Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests
May 04, 2021 16:05 ET | Exagen Inc.
SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, Allegheny Health Network (AHN) Research Institute and the AHN Autoimmunity...
ScipherTM.png
Scipher Applies Spectra™ Platform to Discover Drugs Targeting Autoimmune Patients Refractory to Existing Therapies
May 04, 2021 08:00 ET | Scipher Medicine Corporation
- Leverages large genomic database from Scipher’s testing business.- Proven Spectra™ platform brings precision therapeutics to autoimmune diseases.- Program commercialized through pharma partnerships....
Exagen_Full_RGB_Yahoo_600x216.png
Exagen Announces New Campaign and Initiatives for Lupus Awareness Month
May 03, 2021 08:25 ET | Exagen Inc.
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of...
Exagen_Full_RGB_Yahoo_600x216.png
Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021
April 27, 2021 16:05 ET | Exagen Inc.
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2021 after...
Exagen_Full_RGB_Yahoo_600x216.png
Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases
March 29, 2021 08:25 ET | Exagen Inc.
SAN DIEGO, March 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
ScipherTM.png
Scipher Medicine Announces $82 Million Financing
March 24, 2021 08:00 ET | Scipher Medicine Corporation
-aMoon and Northpond Ventures led the round.-Additional investors include Echo Health Ventures, Khosla Ventures and Alumni Ventures.-Financing will support commercialization of precision medicine...
Exagen_Full_RGB_Yahoo_600x216.png
Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results
March 16, 2021 16:05 ET | Exagen Inc.
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...
Logo V rgb original.jpg
BlossomHill Therapeutics Closes $71M Series A Financing
March 03, 2021 16:01 ET | BlossomHill Therapeutics, Inc.
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced today that the company raised $71...
Emergen logo.png
Human Microbiome Therapeutics Market Size Worth USD 1,098.4 Million by 2027 | Rising Government Initiatives In Microbiome Research Projects And Increasing Drug-Related Side Effects Are Driving The Industry Growth, says Emergen Research
March 02, 2021 08:59 ET | Emergen Research
Vancouver, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) -- The global Human Microbiome Therapeutics Market is forecasted to be worth USD 1,098.4 Million by 2027, according to a current analysis...
Exagen_Full_RGB_Yahoo_600x216.png
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021
March 02, 2021 08:00 ET | Exagen Inc.
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading autoimmune organization, will release financial results for the quarter and year ended December 31, 2020 after the...